Board of Directors
Gösta Johannesson, Chairman of the Board
Chairman of the Remuneration Committee
Born 1959. B.Sc. in Business Administration and Economics. Senior adviser at Bure Equity AB. Other Board assignments: Vice Chairman of the board in Interflora AB, board member in Mentice AB (publ), Yubico AB, Scandinova Systems AB and others. Earlier Partner at Provider Venture Partners, before that executive position at Öhman Fondkommission and Handelsbanken Markets. Shareholding in XVIVO Perfusion: 2 000 shares.
Camilla Öberg
Chairman of the Audit Committee
Born 1964, B.Sc. in Business Administration at Stockholm school of economics. CFO Cybercom Group from 2012 and before that CFO in Logica. Before that management positions in WM-data, SEB, Lexicon and Swegro Group. Other Board assignments: Board member in Instalco. Shareholding in XVIVO Perfusion: 1 076 shares.
Folke Nilsson
Member of the Audit Committee
Born 1950. MD, PhD. at University of Gothenburg. Specialist in Cardiothoracic surgery. Earlier responsible for Heart and Lung transplantation at Sahlgrenska Universitetssjukhuset. Currently General practitioner. No other Board assignments. Shareholding in XVIVO Perfusion: – shares.
Lena Höglund
Member of the Board
Born 1960. 30 years’ experience from leading commercial positions at Elekta. VP Clinical Marketing Neuro Solutions & Chairman, Leksell Gamma Knife Society, Elekta. Other Board assignments: Bergvik Sweden AB, Bergvik Group AB. Shareholding in XVIVO Perfusion: – shares.
Yvonne Mårtensson
Member of the Remuneration Committee and the Audit Committee
Born 1953. M. Sc. Ind. Eng. Independent Board Director and Business Advisor. Other Board assignments: Chairman of the board in Elos Medtech AB and Lyfstone A/S. More than thirty years’ experience from leading positions in fast growing companies primarily within medtech and diagnostic. Earlier CEO for CellaVision AB during 1998-2014. Shareholding in XVIVO Perfusion: 3 000 shares
Lars Henriksson
Member of the Board
Born 1955. DDM at Gothenburg University. Over thirty years’ experience from leading commercial positions in the medtech industry. Previously Executive VP at Dentsply and Dentsply Sirona. Other Board assignments: Board member at AddBio. Shareholding in XVIVO Perfusion: 900 shares
